Fig. 1
From: Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-4588-y/MediaObjects/12885_2018_4588_Fig1_HTML.png)
Expression of p-Nrf2 in C-HCC samples and in cultured hepatoma cell lines. a Immunohistochemical analysis of the expression of p-Nrf2, and hematoxylin-eosin (HE) staining in C-HCC specimens (#1 and #2) and a non-HCC specimen without either HCV or HBV infection. Bars, 50 μm. b Immunofluorescent analysis of the p-Nrf2 and the HCV core protein with nuclear staining (DAPI), and their merged images in the cell lines. c Immunoblot analysis of the Nrf2 protein in the cultured hepatoma cell lines after knockdown with siRNA against Nrf2 or control RNA. Beta-actin was used for validation of sample loading